These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32538874)

  • 41. Investigating the knowledge, perception, and practice of healthcare practitioners toward rational use of compounded medications and its contribution to antimicrobial resistance: a cross-sectional study.
    Assefa D; Paulos G; Kebebe D; Alemu S; Reta W; Mulugeta T; Gashe F
    BMC Health Serv Res; 2022 Feb; 22(1):243. PubMed ID: 35197075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FDA approved vs. Pharmacy compounded 17-OHPC-current issues for obstetricians to consider in reducing recurrent preterm birth.
    Gandell DL; Randell MD; Gudeman JL
    Curr Med Res Opin; 2020 Aug; 36(8):1393-1401. PubMed ID: 32544354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current Trends and Emerging Priorities in Compounded Preparations for Children.
    Parrish RH
    Int J Pharm Compd; 2018; 22(5):358-366. PubMed ID: 30384335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Extent of Extemporaneous Preparation and Regulatory Framework of Extemporaneous Compounding in Latvia.
    Kiseļova O; Mauriņa B; Šidlovska V; Zvejnieks J
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31454896
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug shortages and training.
    Gumpper KF
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):42S-43S. PubMed ID: 22301327
    [No Abstract]   [Full Text] [Related]  

  • 50. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency and Severity of Parenteral Nutrition Medication Errors at a Large Children's Hospital After Implementation of Electronic Ordering and Compounding.
    MacKay M; Anderson C; Boehme S; Cash J; Zobell J
    Nutr Clin Pract; 2016 Apr; 31(2):195-206. PubMed ID: 26214511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 53. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poor preservation efficacy versus quality and safety of pediatric extemporaneous liquids.
    Ghulam A; Keen K; Tuleu C; Wong IC; Long PF
    Ann Pharmacother; 2007 May; 41(5):857-60. PubMed ID: 17440007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless arithmetic nullifies careful compounding".
    Newton DW
    Int J Pharm Compd; 2015; 19(6):444-6. PubMed ID: 26891557
    [No Abstract]   [Full Text] [Related]  

  • 56. Overview of the parenteral nutrition use process.
    Boullata JI
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):10S-13S. PubMed ID: 22275321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Requirements regarding compounded pharmaceutical preparation].
    Neef CK
    Ned Tijdschr Geneeskd; 2010; 154():A2032. PubMed ID: 20858313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The standardization of nonsterile compounding: a study in quality control and assessment for hormone compounding.
    Wiley TS; Odegard RD; Raden J; Haraldsen JT
    Int J Pharm Compd; 2014; 18(2):162-8. PubMed ID: 24881121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perceptions of pharmaceutical care among pharmacists offering compounding services.
    Yancey V; Yakimo R; Perry A; McPherson TB
    J Am Pharm Assoc (2003); 2008; 48(4):508-14. PubMed ID: 18653427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review of drug utilization patterns in NICUs worldwide.
    Krzyżaniak N; Pawłowska I; Bajorek B
    J Clin Pharm Ther; 2016 Dec; 41(6):612-620. PubMed ID: 27578606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.